These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 21501938

  • 1. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients.
    de Assis RA, Ribeiro AA, Kay FU, Rosemberg LA, Nomura CH, Loggetto SR, Araujo AS, Fabron Junior A, de Almeida Veríssimo MP, Baldanzi GR, Espósito BP, Baroni RH, Wood JC, Hamerschlak N.
    Eur J Radiol; 2012 Jul; 81(7):1465-70. PubMed ID: 21501938
    [Abstract] [Full Text] [Related]

  • 2. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
    Hashemieh M, Azarkeivan A, Akhlaghpoor S, Shirkavand A, Sheibani K.
    Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
    [Abstract] [Full Text] [Related]

  • 3. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M.
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [Abstract] [Full Text] [Related]

  • 4. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
    Au WY, Lam WW, Chu W, Tam S, Wong WK, Liang R, Ha SY.
    Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
    [Abstract] [Full Text] [Related]

  • 5. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.
    Alexopoulou E, Stripeli F, Baras P, Seimenis I, Kattamis A, Ladis V, Efstathopoulos E, Brountzos EN, Kelekis AD, Kelekis NL.
    J Magn Reson Imaging; 2006 Feb; 23(2):163-70. PubMed ID: 16374880
    [Abstract] [Full Text] [Related]

  • 6. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P, Giua R, De Marco S, Bonetti MG, Amurri B, Masi C, Lazzari G, Rizzo C, Cervellera M, Peluso A.
    Haematologica; 1995 Feb; 80(5):398-404. PubMed ID: 8566878
    [Abstract] [Full Text] [Related]

  • 7. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
    Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O.
    Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
    [Abstract] [Full Text] [Related]

  • 8. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major.
    Papakonstantinou O, Alexopoulou E, Economopoulos N, Benekos O, Kattamis A, Kostaridou S, Ladis V, Efstathopoulos E, Gouliamos A, Kelekis NL.
    J Magn Reson Imaging; 2009 Apr; 29(4):853-9. PubMed ID: 19306409
    [Abstract] [Full Text] [Related]

  • 9. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.
    Tony S, Daar S, Elshinawy M, Al-Zadjaly S, Al-Khabori M, Wali Y.
    Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111
    [Abstract] [Full Text] [Related]

  • 10. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A, Natsiopoulos K, Kleanthous M, Ioannou A, Kontoghiorghes GJ.
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [Abstract] [Full Text] [Related]

  • 11. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major.
    Midiri M, Lo Casto A, Sparacia G, D'Angelo P, Malizia R, Finazzo M, Montalto G, Solbiati L, Lagalla R, De Maria M.
    AJR Am J Roentgenol; 1999 Jul; 173(1):187-92. PubMed ID: 10397124
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D.
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [Abstract] [Full Text] [Related]

  • 13. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
    Noetzli LJ, Panigrahy A, Mittelman SD, Hyderi A, Dongelyan A, Coates TD, Wood JC.
    Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
    [Abstract] [Full Text] [Related]

  • 14. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T.
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [Abstract] [Full Text] [Related]

  • 15. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M, Rahimi M, Darvishi-Khezri H, Gholizadeh N, Akbarzadeh R, Aliasgharian A.
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [Abstract] [Full Text] [Related]

  • 16. Use of fat suppression in R₂ relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients.
    Papakonstantinou O, Foufa K, Benekos O, Alexopoulou E, Mademli M, Balanika A, Economopoulos N, Kelekis NL.
    Magn Reson Imaging; 2012 Sep; 30(7):926-33. PubMed ID: 22495242
    [Abstract] [Full Text] [Related]

  • 17. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X, Jing Y, Pei F, Chen J, Feng X, He Y, Zhang Y, Li C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [Abstract] [Full Text] [Related]

  • 18. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
    Ghoti H, Goitein O, Koren A, Levin C, Kushnir T, Rachmilewitz E, Konen E.
    Eur J Haematol; 2010 Jan 01; 84(1):59-63. PubMed ID: 19793250
    [Abstract] [Full Text] [Related]

  • 19. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM, Liem RI, Rigsby CK, Labotka RJ, DeFreitas RA, Thompson AA.
    Br J Haematol; 2016 Nov 01; 175(4):705-713. PubMed ID: 27507431
    [Abstract] [Full Text] [Related]

  • 20. Iron overload in Brazilian thalassemic patients.
    Assis RA, Kay FU, Rosemberg LA, Parma AH, Nomura CH, Loggetto SR, Araujo Ada S, Fabron Junior A, Veríssimo MP, Baldanzi GR, Steagal MA, Velloso CA, Espósito BP, Nakashima SS, Diniz Mda S, Tricta F, Baroni RH, Funari MB, Wood JC.
    Einstein (Sao Paulo); 2011 Jun 01; 9(2):165-72. PubMed ID: 26760810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.